Oncobiologics' Corporate Minority Round

Oncobiologics raised a round of funding on July 16, 2014. Investors include Strides Shasun.

Oncobiologics is a privately-held biopharmaceutical company focused on developing and commercializing monoclonal antibody biosimilar therapeutics. It is advancing its pipeline of 11 biosimilar product…

Articles about Oncobiologics' Corporate Minority Round: